GlassScriptPhysician profile
Christopher Merrell Funk
NPI 1720079528
$6,026.95
in general payments reported to CMS, 2019-2025
28 companies · $1,895 in 2025
The $1,895 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $147 · 2021: $457 · 2022: $269 · 2023: $618 · 2024: $2,427 · 2025: $1,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4,400 · Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,400.18 |
| Food and Beverage | $540.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $3,828.12 | 2024-2025 | Lapilock |
| Fusion Orthopedics, LLC. | $572.06 | 2023-2024 | Lapilock |
| Treace Medical Concepts, INC. | $332.69 | 2021-2023 | |
| Orthofix Medical, INC. | $294.08 | 2019-2025 | Physio-Stim |
| Stryker Corporation | $163.75 | 2024-2025 | Prostep Mica, Sonicanchor, Ortholoc 2 Lapifuse |
| Grt US Holding, INC. | $97.83 | 2021-2022 | |
| Organogenesis INC. | $89.37 | 2020-2022 | |
| Depuy Synthes Sales INC. | $70.46 | 2019 | |
| Smith+Nephew, INC. | $65.83 | 2019-2022 | |
| Nevro Corp. | $58.97 | 2023-2024 | Senza |
| Kowa Pharmaceuticals America, INC. | $51.95 | 2023 | Seglentis |
| Tactile Systems Technology INC | $48.33 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $32.96 | 2019-2023 | Nuzyra |
| Abbvie INC. | $31.04 | 2021-2022 | |
| Medtronic, INC. | $29.39 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $28.68 | 2021-2022 | |
| Abbott Laboratories | $28.47 | 2023 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $28.39 | 2023 | Iovera, Exparel |
| Musculoskeletal Transplant Foundation INC. | $28.31 | 2022 | |
| Bioventus LLC | $22.99 | 2022 | |
| Biocomposites INC | $22.20 | 2024 | |
| Djo, LLC | $18.89 | 2022 | |
| Amgen INC. | $15.33 | 2024 | Krystexxa |
| Merck Sharp & Dohme LLC | $15.00 | 2019 | |
| Osiris Therapeutics INC. | $14.48 | 2019 | |
| Medela LLC | $13.28 | 2021 | |
| Wright Medical Technology, INC. | $12.33 | 2019 | |
| Trice Medical, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Funk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.